Assessment of gastrointestinal involvement
- PMID: 12889216
Assessment of gastrointestinal involvement
Abstract
The purpose of this paper is to identify a list of clinical, laboratory and instrumental tools suitable to assess the presence of gastrointestinal involvement in SSc patients to be included in clinical investigational studies. The pertinent literature was reviewed to select those variables which have been demonstrated to be valid, reliable and feasible. A minimal core set of variables has been identified to be used in clinical investigation for the assessment of esophagus, stomach, small intestine, colon and anorectum involvement in scleroderma patients.
Similar articles
-
Assessment of vascular involvement.Clin Exp Rheumatol. 2003;21(3 Suppl 29):S9-14. Clin Exp Rheumatol. 2003. PMID: 12889215 Review.
-
Assessment of disease activity.Clin Exp Rheumatol. 2003;21(3 Suppl 29):S39-41. Clin Exp Rheumatol. 2003. PMID: 12889221 Review.
-
Assessment of kidney involvement.Clin Exp Rheumatol. 2003;21(3 Suppl 29):S29-31. Clin Exp Rheumatol. 2003. PMID: 12889219 Review.
-
A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis.Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101666. doi: 10.1016/j.berh.2021.101666. Epub 2021 Mar 4. Best Pract Res Clin Rheumatol. 2021. PMID: 33676855 Free PMC article. Review.
-
Assessment of lung involvement.Clin Exp Rheumatol. 2003;21(3 Suppl 29):S19-23. Clin Exp Rheumatol. 2003. PMID: 12889217 Review.
Cited by
-
A case of advanced systemic sclerosis with severe GERD successfully treated with acotiamide.Surg Case Rep. 2016 Dec;2(1):36. doi: 10.1186/s40792-016-0162-5. Epub 2016 Apr 13. Surg Case Rep. 2016. PMID: 27072944 Free PMC article.
-
Evaluation and management of esophageal manifestations in systemic sclerosis.Ann Gastroenterol. 2018 Mar-Apr;31(2):165-170. doi: 10.20524/aog.2018.0228. Epub 2018 Jan 18. Ann Gastroenterol. 2018. PMID: 29507463 Free PMC article. Review.
-
Management of gastrointestinal involvement in scleroderma.Curr Treatm Opt Rheumatol. 2015 Mar 1;1(1):82-105. doi: 10.1007/s40674-014-0005-0. Curr Treatm Opt Rheumatol. 2015. PMID: 26005632 Free PMC article.
-
Oral manifestations of Systemic Sclerosis and Correlation with anti-Topoisomerase I Antibodies (SCL-70).Med Arch. 2015 Jun;69(3):153-6. doi: 10.5455/medarh.2015.69.153-156. Epub 2015 Jun 10. Med Arch. 2015. PMID: 26261381 Free PMC article.
-
Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.Curr Rheumatol Rep. 2012 Feb;14(1):22-9. doi: 10.1007/s11926-011-0217-3. Curr Rheumatol Rep. 2012. PMID: 22105546 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical